 Bioprocess Automation Market Size, Share & Trends Analysis Report By Product & Services (Services & Support, Process Automation Hardware, Automation Consumables & Accessories), By Process Stage (Upstream), By End Use, By Region, And Segment Forecasts, 2026 - 2033
Bioprocess Automation Market Summary The global bioprocess automation market size was estimated at USD 8.6 billion in 2025 and is projected to reach USD 22.2 billion by 2033, growing at a CAGR o... もっと見る
英語原文をAIを使って翻訳しています。
SummaryBioprocess Automation Market SummaryThe global bioprocess automation market size was estimated at USD 8.6 billion in 2025 and is projected to reach USD 22.2 billion by 2033, growing at a CAGR of 12.8% from 2026 to 2033, driven by increasing demand for biologics, progress in AI and robotics, and the need for regulatory compliance. Rising Demand for Biologics The rising demand for biologics is among the most significant drivers of the bioprocess automation industry. Over the past decade, there has been a rapid expansion of monoclonal antibody development and vaccine production, gene therapy development, and all other biologic products because these treatments effectively address complicated medical conditions, which include cancer, autoimmune disorders, and rare genetic diseases. For these biologics to remain effective and to maintain high quality, manufacturing procedures must be extremely controlled, scalable, and precise. There is a significant need for fully automated bioprocess solutions because traditional manual or semi-automated production methods are frequently labor-intensive, prone to mistakes, and inadequate to meet the expanding market demand. Bioprocess automation is becoming essential as healthcare increasingly relies on biologics. It optimizes workflows, enhances consistency, boosts throughput, and reduces costs, variability, and production time using robotics, AI, and advanced monitoring. Need for Efficiency & Cost Reduction The need for cost and efficiency reduction largely drives the market for bioprocess automation. Manufacturing biopharmaceuticals is a complicated and resource-intensive process that frequently requires highly qualified staff, careful observation, and strict protocol adherence. The manual and semi-automated processes, which need extensive human effort, lead to operational errors and result in production problems, including batch failures, product defects, and increased production costs. The implementation of automated systems enables businesses to achieve higher productivity levels while reducing their need for human workers and decreasing operational mistakes, which results in more reliable production outcomes. Automation increases productivity, drastically reduces operating costs, and improves reliability. Manufacturers can more effectively meet growing market demand thanks to automated bioprocessing systems' ability to run continuously with little downtime, optimize resource usage, and speed up production cycles. In an increasingly cost-sensitive healthcare environment, the ability to produce high-quality biologics at a lower cost also helps businesses stay competitive. As a result, the need for cost-effectiveness and operational efficiency keeps driving global investments in bioprocess automation technologies. Global Bioprocess Automation Market Report Segmentation This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global bioprocess automation market based on product & service, process stage, end use, and region: • Product & Service Outlook (Revenue, USD Million, 2021 - 2033) • Automation Consumables & Accessories • Process Automation Hardware • Software & Control Systems • Integrated & Turnkey Solutions • Services & Support • Process Stage Outlook (Revenue, USD Million, 2021 - 2033) • Upstream • Downstream • Process Development & Scale-up • Fill/Finish & Packaging automation • Quality Control & PAT • End Use Outlook (Revenue, USD Million, 2021 - 2033) • Pharmaceutical & biotech manufacturers • CDMOs & CMOs • Academic & research institutions • Contract testing & analytical labs • Others • Regional Outlook (Revenue, USD Million, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o Germany o UK o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o China o India o Japan o South Korea o Australia o Thailand • Latin America o Brazil o Argentina • Middle East and Africa (MEA) o South Africa o Saudi Arabia o UAE o Kuwait Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation and Scope 1.2. Market Definitions 1.2.1. Product & Services 1.2.2. Process Stage 1.2.3. End use 1.3. Information analysis 1.4. Market formulation & data visualization 1.5. Data validation & publishing 1.6. Information Procurement 1.6.1. Primary Research 1.7. Information or Data Analysis 1.8. Market Formulation & Validation 1.9. Market Details 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Segment Snapshot 2.3. Competitive Landscape Snapshot Chapter 3. Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Ancillary Market Outlook 3.2. Market Trends and Outlook 3.3. Market Dynamics 3.3.1. Market Driver Impact Analysis 3.3.1.1. Rising demand for biologics 3.3.1.2. Need for efficiency and cost reduction 3.3.1.3. Advancements in AI, robotics, and IoT 3.3.1.4. Transition to single-use and continuous processing 3.3.2. Market Restraint Impact Analysis 3.3.2.1. High initial investment costs 3.3.2.2. Regulatory and compliance challenges 3.3.3. Market Opportunity Analysis 3.3.4. Market Challenge Analysis 3.4. Case Study Insights 3.5. Business Environment Analysis 3.5.1. PESTLE Analysis 3.5.2. PORTER’S Five Forces Analysis Chapter 4. Product & Services Business Analysis 4.1. Product & Services Segment Dashboard 4.2. Global Bioprocess Automation Market Product & Services, Movement Analysis 4.3. Global Bioprocess Automation Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million) 4.4. Automation Consumables & Accessories 4.4.1. Global automation consumables & accessories market estimates and forecasts, 2021 - 2033 (USD Million) 4.5. Process Automation Hardware 4.5.1. Global Process Automation Hardware market estimates and forecasts, 2021 - 2033 (USD Million) 4.6. Software & Control Systems 4.6.1. Global software & control systems market estimates and forecasts, 2021 - 2033 (USD Million) 4.7. Integrated & Turnkey Solutions 4.7.1. Global integrated & turnkey solutions market estimates and forecasts, 2021 - 2033 (USD Million) 4.8. Services & Support 4.8.1. Global services & support market estimates and forecasts, 2021 - 2033 (USD Million) Chapter 5. Process Stage Business Analysis 5.1. Process Stage Segment Dashboard 5.2. Global Bioprocess Automation Market Process Stage, Movement Analysis 5.3. Global Bioprocess Automation Market Size & Trend Analysis, by Process Stage, 2021 to 2033 (USD Million) 5.4. Upstream 5.4.1. Global upstream market estimates and forecasts, 2021 - 2033 (USD Million) 5.5. Downstream 5.5.1. Global downstream market estimates and forecasts, 2021 - 2033 (USD Million) 5.6. Process Development & Scale-up 5.6.1. Global process development & scale-up market estimates and forecasts, 2021 - 2033 (USD Million) 5.7. Fill/Finish & Packaging automation 5.7.1. Global fill/finish & packaging automation market estimates and forecasts, 2021 - 2033 (USD Million) 5.8. Quality Control & PAT 5.8.1. Global quality control & PAT market estimates and forecasts, 2021 - 2033 (USD Million) Chapter 6. End Use Business Analysis 6.1. End Use Segment Dashboard 6.2. Global Bioprocess Automation Market End Use, Movement Analysis 6.3. Global Bioprocess Automation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million) 6.4. Pharmaceutical & biotech manufacturers 6.4.1. Global Pharmaceutical & biotech manufacturers market estimates and forecasts, 2021 - 2033 (USD Million) 6.5. CDMOs & CMOs 6.5.1. Global CDMOs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million) 6.6. Academic & research institutions 6.6.1. Global academic & research institutions market estimates and forecasts, 2021 - 2033 (USD Million) 6.7. Contract testing & analytical labs 6.7.1. Global contract testing & analytical labs market estimates and forecasts, 2021 - 2033 (USD Million) 6.8. Others 6.8.1. Global others market estimates and forecasts, 2021 - 2033 (USD Million) Chapter 7. Bioprocess Automation Market: Regional Estimates and Trend Analysis, by Product & Services, Process Stage & End Use. 7.1. Regional Dashboard 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033 7.3. North America 7.3.1. North America bioprocess automation market, 2021 - 2033 (USD Million) 7.3.2. U.S. 7.3.2.1. Key Country Dynamics 7.3.2.2. Target Disease Prevalence 7.3.2.3. Competitive Scenario 7.3.2.4. Regulatory Framework 7.3.2.5. U.S. bioprocess automation market, 2021 - 2033 (USD Million) 7.3.3. Canada 7.3.3.1. Key Country Dynamics 7.3.3.2. Target Disease Prevalence 7.3.3.3. Competitive Scenario 7.3.3.4. Regulatory Framework 7.3.3.5. Canada bioprocess automation market, 2021 - 2033 (USD Million) 7.3.4. Mexico 7.3.4.1. Key Country Dynamics 7.3.4.2. Target Disease Prevalence 7.3.4.3. Competitive Scenario 7.3.4.4. Regulatory Framework 7.3.4.5. Mexico bioprocess automation market, 2021 - 2033 (USD Million) 7.4. Europe 7.4.1. Europe bioprocess automation market, 2021 - 2033 (USD Million) 7.4.2. UK 7.4.2.1. Key Country Dynamics 7.4.2.2. Target Disease Prevalence 7.4.2.3. Competitive Scenario 7.4.2.4. Regulatory Framework 7.4.2.5. UK bioprocess automation market, 2021 - 2033 (USD Million) 7.4.3. Germany 7.4.3.1. Key Country Dynamics 7.4.3.2. Target Disease Prevalence 7.4.3.3. Competitive Scenario 7.4.3.4. Regulatory Framework 7.4.3.5. Germany bioprocess automation market, 2021 - 2033 (USD Million) 7.4.4. France 7.4.4.1. Key Country Dynamics 7.4.4.2. Target Disease Prevalence 7.4.4.3. Competitive Scenario 7.4.4.4. Regulatory Framework 7.4.4.5. France bioprocess automation market, 2021 - 2033 (USD Million) 7.4.5. Italy 7.4.5.1. Key Country Dynamics 7.4.5.2. Target Disease Prevalence 7.4.5.3. Competitive Scenario 7.4.5.4. Regulatory Framework 7.4.5.5. Italy bioprocess automation market, 2021 - 2033 (USD Million) 7.4.6. Spain 7.4.6.1. Key Country Dynamics 7.4.6.2. Target Disease Prevalence 7.4.6.3. Competitive Scenario 7.4.6.4. Regulatory Framework 7.4.6.5. Spain bioprocess automation market, 2021 - 2033 (USD Million) 7.4.7. Denmark 7.4.7.1. Key Country Dynamics 7.4.7.2. Target Disease Prevalence 7.4.7.3. Competitive Scenario 7.4.7.4. Regulatory Framework 7.4.7.5. Denmark bioprocess automation market, 2021 - 2033 (USD Million) 7.4.8. Sweden 7.4.8.1. Key Country Dynamics 7.4.8.2. Target Disease Prevalence 7.4.8.3. Competitive Scenario 7.4.8.4. Regulatory Framework 7.4.8.5. Sweden bioprocess automation market, 2021 - 2033 (USD Million) 7.4.9. Norway 7.4.9.1. Key Country Dynamics 7.4.9.2. Target Disease Prevalence 7.4.9.3. Competitive Scenario 7.4.9.4. Regulatory Framework 7.4.9.5. Norway bioprocess automation market, 2021 - 2033 (USD Million) 7.5. Asia Pacific 7.5.1. Asia Pacific bioprocess automation market, 2021 - 2033 (USD Million) 7.5.2. Japan 7.5.2.1. Key Country Dynamics 7.5.2.2. Target Disease Prevalence 7.5.2.3. Competitive Scenario 7.5.2.4. Regulatory Framework 7.5.2.5. Japan bioprocess automation market, 2021 - 2033 (USD Million) 7.5.3. China 7.5.3.1. Key Country Dynamics 7.5.3.2. Target Disease Prevalence 7.5.3.3. Competitive Scenario 7.5.3.4. Regulatory Framework 7.5.3.5. China bioprocess automation market, 2021 - 2033 (USD Million) 7.5.4. India 7.5.4.1. Key Country Dynamics 7.5.4.2. Target Disease Prevalence 7.5.4.3. Competitive Scenario 7.5.4.4. Regulatory Framework 7.5.4.5. India bioprocess automation market, 2021 - 2033 (USD Million) 7.5.5. Singapore 7.5.5.1. Key Country Dynamics 7.5.5.2. Target Disease Prevalence 7.5.5.3. Competitive Scenario 7.5.5.4. Regulatory Framework 7.5.5.5. Singapore bioprocess automation market, 2021 - 2033 (USD Million) 7.5.6. Australia 7.5.6.1. Key Country Dynamics 7.5.6.2. Target Disease Prevalence 7.5.6.3. Competitive Scenario 7.5.6.4. Regulatory Framework 7.5.6.5. Australia bioprocess automation market, 2021 - 2033 (USD Million) 7.5.7. Thailand 7.5.7.1. Key Country Dynamics 7.5.7.2. Target Disease Prevalence 7.5.7.3. Competitive Scenario 7.5.7.4. Regulatory Framework 7.5.7.5. Thailand bioprocess automation market, 2021 - 2033 (USD Million) 7.5.8. South Korea 7.5.8.1. Key Country Dynamics 7.5.8.2. Target Disease Prevalence 7.5.8.3. Competitive Scenario 7.5.8.4. Regulatory Framework 7.5.8.5. South Korea bioprocess automation market, 2021 - 2033 (USD Million) 7.6. Latin America 7.6.1. Latin America bioprocess automation market, 2021 - 2033 (USD Million) 7.6.2. Brazil 7.6.2.1. Key Country Dynamics 7.6.2.2. Target Disease Prevalence 7.6.2.3. Competitive Scenario 7.6.2.4. Regulatory Framework 7.6.2.5. Brazil bioprocess automation market, 2021 - 2033 (USD Million) 7.6.3. Argentina 7.6.3.1. Key Country Dynamics 7.6.3.2. Target Disease Prevalence 7.6.3.3. Competitive Scenario 7.6.3.4. Regulatory Framework 7.6.3.5. Argentina bioprocess automation market, 2021 - 2033 (USD Million) 7.7. MEA 7.7.1. MEA bioprocess automation market, 2021 - 2033 (USD Million) 7.7.2. South Africa 7.7.2.1. Key Country Dynamics 7.7.2.2. Target Disease Prevalence 7.7.2.3. Competitive Scenario 7.7.2.4. Regulatory Framework 7.7.2.5. South Africa bioprocess automation market, 2021 - 2033 (USD Million) 7.7.3. Saudi Arabia 7.7.3.1. Key Country Dynamics 7.7.3.2. Target Disease Prevalence 7.7.3.3. Competitive Scenario 7.7.3.4. Regulatory Framework 7.7.3.5. Saudi Arabia bioprocess automation market, 2021 - 2033 (USD Million) 7.7.4. UAE 7.7.4.1. Key Country Dynamics 7.7.4.2. Target Disease Prevalence 7.7.4.3. Competitive Scenario 7.7.4.4. Regulatory Framework 7.7.4.5. UAE bioprocess automation market, 2021 - 2033 (USD Million) 7.7.5. Kuwait 7.7.5.1. Key Country Dynamics 7.7.5.2. Target Disease Prevalence 7.7.5.3. Competitive Scenario 7.7.5.4. Regulatory Framework 7.7.5.5. Kuwait bioprocess automation market, 2021 - 2033 (USD Million) Chapter 8. Competitive Landscape 8.1. Company Categorization 8.2. Strategy Mapping 8.3. Company Market Position Analysis, 2025 8.4. Company Profiles/Listing 8.4.1. Thermo Fisher Scientific Inc. 8.4.1.1. Overview 8.4.1.2. Financial Performance 8.4.1.3. Product Benchmarking 8.4.1.4. Strategic Initiatives 8.4.2. Sartorius AG 8.4.2.1. Overview 8.4.2.2. Financial Performance 8.4.2.3. Product Benchmarking 8.4.2.4. Strategic Initiatives 8.4.3. Parker Hannifin Corp 8.4.3.1. Overview 8.4.3.2. Financial Performance 8.4.3.3. Product Benchmarking 8.4.3.4. Strategic Initiatives 8.4.4. Merck KGaA 8.4.4.1. Overview 8.4.4.2. Financial Performance 8.4.4.3. Product Benchmarking 8.4.4.4. Strategic Initiatives 8.4.5. Eppendorf SE 8.4.5.1. Overview 8.4.5.2. Financial Performance 8.4.5.3. Product Benchmarking 8.4.5.4. Strategic Initiatives 8.4.6. SIA Bioreactors.net 8.4.6.1. Overview 8.4.6.2. Product Benchmarking 8.4.6.3. Strategic Initiatives 8.4.7. Senieer 8.4.7.1. Overview 8.4.7.2. Product Benchmarking 8.4.7.3. Strategic Initiatives 8.4.8. Getinge 8.4.8.1. Overview 8.4.8.2. Financial Performance 8.4.8.3. Product Benchmarking 8.4.8.4. Strategic Initiatives 8.4.9. Repligen Corporation 8.4.9.1. Overview 8.4.9.2. Financial Performance 8.4.9.3. Product Benchmarking 8.4.9.4. Strategic Initiatives List of Tables/GraphsList of TablesTable 1. List of Secondary Sources Table 2. List of Abbreviations Table 3. Global Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 4. Global Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 5. Global Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 6. Global Bioprocess Automation Market, by Region, 2021 - 2033 (USD Million) Table 7. North America Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million) Table 8. North America Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 9. North America Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 10. North America Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 11. U.S. Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 12. U.S. Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 13. U.S. Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 14. Canada Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 15. Canada Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 16. Canada Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 17. Mexico Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 18. Mexico Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 19. Mexico Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 20. Europe Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million) Table 21. Europe Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 22. Europe Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 23. Europe Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 24. Germany Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 25. Germany Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 26. Germany Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 27. UK Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 28. UK Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 29. UK Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 30. France Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 31. France Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 32. France Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 33. Italy Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 34. Italy Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 35. Italy Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 36. Spain Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 37. Spain Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 38. Spain Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 39. Denmark Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 40. Denmark Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 41. Denmark Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 42. Norway Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 43. Norway Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 44. Norway Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 45. Sweden Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 46. Sweden Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 47. Sweden Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 48. Asia Pacific Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million) Table 49. Asia Pacific Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 50. Asia Pacific Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 51. Asia Pacific Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 52. China Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 53. China Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 54. China Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 55. Japan Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 56. Japan Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 57. Japan Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 58. India Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 59. India Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 60. India Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 61. South Korea Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 62. South Korea Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 63. South Korea Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 64. Australia Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 65. Australia Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 66. Australia Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 67. Thailand Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 68. Thailand Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 69. Thailand Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 70. Latin America Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million) Table 71. Latin America Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 72. Latin America Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 73. Latin America Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 74. Brazil Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 75. Brazil Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 76. Brazil Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 77. Argentina Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 78. Argentina Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 79. Argentina Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 80. Middle East and Africa Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million) Table 81. Middle East and Africa Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 82. Middle East and Africa Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 83. Middle East and Africa Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 84. South Africa Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 85. South Africa Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 86. South Africa Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 87. Saudi Arabia Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 88. Saudi Arabia Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 89. Saudi Arabia Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 90. UAE Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 91. UAE Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 92. UAE Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million) Table 93. Kuwait Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million) Table 94. Kuwait Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million) Table 95. Kuwait Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)List of Figures Fig. 1 Bioprocess automation market segmentation Fig. 2 Data analysis models Fig. 3 Market formulation and validation Fig. 4 Data validation & publishing Fig. 5 Market research process Fig. 6 Information procurement Fig. 7 Primary research Fig. 8 Value-chain-based sizing & forecasting Fig. 9 QFD modelling for market share assessment Fig. 10 Market formulation & validation Fig. 11 Commodity flow analysis Fig. 12 Market outlook Fig. 13 Segment snapshot Fig. 14 Competitive landscape snapshot Fig. 15 Market trends & outlook Fig. 16 PESTEL analysis Fig. 17 Porter’s five forces analysis Fig. 18 Bioprocess automation market: Product & Services outlook key takeaways Fig. 19 Bioprocess automation market: Product & Services movement analysis Fig. 20 Automation consumables & accessories market, 2021 - 2033 (USD Million) Fig. 21 Process automation hardware market, 2021 - 2033 (USD Million) Fig. 22 Software & control systems market, 2021 - 2033 (USD Million) Fig. 23 Integrated & turnkey solutions market, 2021 - 2033 (USD Million) Fig. 24 Services & support market, 2021 - 2033 (USD Million) Fig. 25 Bioprocess automation market: Process Stage outlook key takeaways Fig. 26 Bioprocess automation market: Process Stage movement analysis Fig. 27 Upstream market, 2021 - 2033 (USD Million) Fig. 28 Downstream market, 2021 - 2033 (USD Million) Fig. 29 Process development & scale-up market, 2021 - 2033 (USD Million) Fig. 30 Fill/finish & packaging automation market, 2021 - 2033 (USD Million) Fig. 31 Quality control & PAT market, 2021 - 2033 (USD Million) Fig. 32 Bioprocess automation market: End use outlook key takeaways Fig. 33 Bioprocess automation market: End use movement analysis Fig. 34 Pharmaceutical & biotech manufacturers market, 2021 - 2033 (USD Million) Fig. 35 CDMOs & CMOs market, 2021 - 2033 (USD Million) Fig. 36 Academic & research institutions market, 2021 - 2033 (USD Million) Fig. 37 Contract testing & analytical labs market, 2021 - 2033 (USD Million) Fig. 38 Others market, 2021 - 2033 (USD Million) Fig. 39 Regional marketplace outlook, 2024 & 2033 (USD Million) Fig. 40 Regional marketplace: Key takeaways Fig. 41 North America bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 42 Key country dynamics Fig. 43 U.S. bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 44 Key country dynamics Fig. 45 Canada bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 46 Key country dynamics Fig. 47 Mexico bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 48 Europe bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 49 Key country dynamics Fig. 50 Germany bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 51 Key country dynamics Fig. 52 UK bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 53 Key country dynamics Fig. 54 France bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 55 Key country dynamics Fig. 56 Italy bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 57 Key country dynamics Fig. 58 Spain bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 59 Key country dynamics Fig. 60 Denmark bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 61 Key country dynamics Fig. 62 Sweden bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 63 Key country dynamics Fig. 64 Norway bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million) Fig. 65 Asia Pacific bioprocess automation market estimates and forecast, 2021 - 2033, (USD Million) Fig. 66 Key country dynamics Fig. 67 Japan bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 68 Key country dynamics Fig. 69 China bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 70 Key country dynamics Fig. 71 India bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 72 Key country dynamics Fig. 73 South Korea bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 74 Key country dynamics Fig. 75 Australia bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 76 Key country dynamics Fig. 77 Thailand bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 78 Latin America bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 79 Key country dynamics Fig. 80 Brazil bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 81 Key country dynamics Fig. 82 Argentina bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 83 MEA bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 84 Key country dynamics Fig. 85 South Africa bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 86 Key country dynamics Fig. 87 Saudi Arabia bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 88 Key country dynamics Fig. 89 UAE bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 90 Key country dynamics Fig. 91 Kuwait bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（バイオ薬物）の最新刊レポート
Grand View Research社の 生物分野 での最新刊レポート
本レポートと同じKEY WORD（automation）の最新刊レポートよくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
